• Jupiter Neurosciences Inc (JUNS) Q4 2025 Earnings Call Transcript
  • ASX set to retreat, Wall Street loses steam after Trump’s threat to ‘take out’ Iran; Oil rises
  • Neurocrine to Acquire Soleno Therapeutics for $2.9 Billion in Cash
  • Neurocrine Biosciences to Acquire Soleno Therapeutics for $2.9B
Neurocrine Biosciences - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

Top Publishers

  • The Verge AI

    The Verge AI

    21 followers

  • TechCrunch AI

    TechCrunch AI

    19 followers

  • Crunchbase News AI

    Crunchbase News AI

    15 followers

  • TechRadar

    TechRadar

    15 followers

  • Hacker News

    Hacker News

    13 followers

See More →

Top Creators

  • Ryan Allis

    Ryan Allis

    209 followers

  • Elon Musk

    Elon Musk

    80 followers

  • Sam Altman

    Sam Altman

    68 followers

  • Mark Cuban

    Mark Cuban

    57 followers

  • Jack Dorsey

    Jack Dorsey

    40 followers

See More →

Top Companies

  • SaasRise

    SaasRise

    211 followers

  • Anthropic

    Anthropic

    40 followers

  • OpenAI

    OpenAI

    22 followers

  • Hugging Face

    Hugging Face

    15 followers

  • xAI

    xAI

    12 followers

See More →

Top Investors

  • Andreessen Horowitz

    Andreessen Horowitz

    16 followers

  • Y Combinator

    Y Combinator

    15 followers

  • Sequoia Capital

    Sequoia Capital

    12 followers

  • General Catalyst

    General Catalyst

    8 followers

  • A16Z Crypto

    A16Z Crypto

    5 followers

See More →
NewsDealsSocialBlogsVideosPodcasts
HomeNeurocrine Biosciences
Neurocrine Biosciences logo

Neurocrine Biosciences

0 followers

NBIX

Performance

About Neurocrine Biosciences

Neurocrine Biosciences is a biopharmaceutical company focused on discovering, developing, and commercializing therapies for neurological, neuroendocrine, and neuropsychiatric disorders. With a heritage of scientific founders, the company emphasizes long-term research and clinical development to address significant unmet medical needs and rare diseases. Its work spans early discovery through clinical studies, aiming to bring safe and effective medicines to patients worldwide. Headquartered in the United States, Neurocrine emphasizes brave science and patient-centered outcomes across its therapeutic areas.

Recent News

Jupiter Neurosciences Inc (JUNS) Q4 2025 Earnings Call Transcript

ASX Set to Retreat, Wall Street Loses Steam After Trump’s Threat to ‘Take Out’ Iran; Oil Rises

Neurocrine to Acquire Soleno Therapeutics for $2.9 Billion in Cash

Recent Deals

Neurocrine Biosciences to Acquire Soleno Therapeutics for $2.9B

April 6, 2026

Key Team Members

Eric Benevich

Chief Commercial Officer

Kyle W. Gano, Ph.D.

Chief Executive Officer

Ingrid Delaet, Ph.D.

Chief Regulatory Officer

Matt Abernethy

Chief Financial Officer

Sanjay Keswani, M.D.

Chief Medical Officer

Key Facts

HQ Location

San Diego, United States

Founded

1992

Employees

1K-5K

Status

Public

Website

https://neurocrine.com